This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +29.41% and +146.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Beyond Air (XAIR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of 35.71% and 17.12%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -37.50% and 88.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Veeva (VEEV) delivered earnings and revenue surprises of 13.22% and 4.27%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of 16.67% and 9.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Bears are Losing Control Over Beyond Air (XAIR), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Beyond Air (XAIR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Beyond Air, Inc. (XAIR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of 6.67% and 32.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Cartesian Therapeutics, Inc. (RNAC) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Cartesian Therapeutics, Inc. (RNAC) delivered earnings and revenue surprises of 11.54% and 93.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Alector (ALEC) delivered earnings and revenue surprises of 18.87% and 6.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of 6.90% and 5.14%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for July 25th
by Zacks Equity Research
BSVN, OKTA, SVM, SFIX and XAIR have been added to the Zacks Rank #1 (Strong Buy) List on July 25, 2024.
Alterity (ATHE) Up on Interim Data From Advance MSA Study
by Zacks Equity Research
Alterity (ATHE) posts positive interim data from the phase II ATH434-202 study evaluating its lead candidate ATH434 for treating patients with multiple system atrophy. Stock rises.
All You Need to Know About Beyond Air (XAIR) Rating Upgrade to Strong Buy
by Zacks Equity Research
Beyond Air (XAIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Beyond Air (XAIR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Beyond Air (XAIR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of 23.40% and 33.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Ahead of Guidewire's (GWRE) Q3 Earnings Release
by Zacks Equity Research
Guidewire's (GWRE) fiscal third-quarter performance is likely to have been driven by strengthening subscription revenues.
Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Beyond Air (XAIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of 18.03% and 20.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of 2.17% and 70.65%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -52.27% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 27th
by Zacks Equity Research
ARAY, XAIR, and EMKR have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2022
Implied Volatility Surging for Beyond Air (XAIR) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Beyond Air (XAIR) stock based on the movements in the options market lately.
Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Beyond Air, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.